10.1016/j.braindev.2010.12.003 29 NguyenP.ChevillardL.GoudaA
[DOI] [PubMed] [Google Scholar] 16.Orlando P., Silvestri S., Galeazzi R., Antonicelli R., Marcheggiani F., Cirilli I., Bacchetti T., Tiano L
for 2m, its 25mcg per IU offering more precise control over your dosage
Axonal fusion is metabolically efficient because it only requires a single connection with the distal axon to the target tissue without reconstructing the entire peripheral terminals from the detached part to the target tissue 2
G-CSF: granulocyte-colony stimulating factor
Phase 2 Clinical Trial# The Phase 2 trial enrolled 469 adults with obesity or overweight and evaluated three subcutaneous dose levels of CT-388 versus placebo over 48 weeks